COVID-19: Oxford Vaccine Group chief hopeful data could go before regulators this year

University of Oxford and AstraZeneca’s experimental COVID-19 vaccine could be sent to regulators this year if scientists and experts are able to cumulate positive data from results, director of Oxford Vaccine Group Andrew Pollard said in a statement on August 24. However, Andrew Pollard said that mandatory research and trials cant be cut short in order to expedite  vaccine for emergency use. 

Speaking to BBC, Pollard said that it may be possible that if cases accrue rapidly in clinical trials, company could have that data before regulators this year. He ded, that re would be a process that needs to be followed in order to make a full assessment of data. Pollard said that process for emergency use authorization was established, however, it still involves having carefully conducted data and evidence that vaccine actually works. A full assessment of data is needed, he stressed. Furr, chief investigator of global clinical trials of vaccine candidate also revealed that AstraZeneca would take data to regulators only when scientists were satisfied with it. His comments come in context to reports of Washington seeking to get emergency approval of vaccine based on a small UK study that involved only 10,000 people.

Re: AstraZeneca Secures Two New Deals With US Government: Report

Re: AstraZeneca Agrees To Supply 400 Million Doses Of Experimental Covid-19 Vaccine For Europe

Fast-track experimental COVID-19 vaccine

Earlier, Trump ministration insisted to fast-track an experimental COVID-19 vaccine ahe of vember elections. With Trump claiming to make COVID-19 vaccine available for American use before end of this year, focus switched to experimental candidate under trials. Furr, Food and Drug ministration (FDA) considered awarding "emergency use authorization" in October. AstraZeneca's chief executive said that potential coronavirus vaccine is likely to provide protection against contracting COVID-19 for at least a year while speaking with state brocaster. Soriot reportedly said company plans to begin delivering vaccine to European countries by end of year 2020 under agreement with Inclusive Vaccine Alliance. British drugmaker signed agreements with Biomedical vanced Research and Development Authority (BARDA) and Defense vanced Research Projects ncy (DARPA) in US and new agreements with companies to double its production from one billion doses to two billion doses.

Re: "Bernie Sanders Is Greatest Loser I've Ever Seen, He Can Lose And Be So Happy": Trump

Re: Trump: Americans Have To 'make this China virus Go Away' And It's Happening

(Im Credit: AP)